接受双美珠单抗治疗的银屑病患者出现体癣和面癣的棘手病例：生物疗法前真菌学筛查的作用

IF 1.6 Q3 MEDICINE, RESEARCH & EXPERIMENTAL

Medical Mycology Case Reports Pub Date : 2024-11-16 DOI:10.1016/j.mmcr.2024.100683

Terenzio Cosio , Ruslana Gaeta Shumak , Cristiana Borselli , Fabio Artosi , Roberta Gaziano , Elena Campione

{"title":"接受双美珠单抗治疗的银屑病患者出现体癣和面癣的棘手病例：生物疗法前真菌学筛查的作用","authors":"Terenzio Cosio , Ruslana Gaeta Shumak , Cristiana Borselli , Fabio Artosi , Roberta Gaziano , Elena Campione","doi":"10.1016/j.mmcr.2024.100683","DOIUrl":null,"url":null,"abstract":"<div><div>Psoriasis is a multifactorial immune-mediated disorder linked to the interleukin (IL)-17 signalling pathway. We present an unusual case of <em>tinea corporis</em> and <em>faciei</em> caused by <em>Trichophyton tonsurans</em> that developed after starting the IL-17A/F inhibitor bimekizumab. Our case underlines how psoriatic patients, treated with IL-17 inhibitors, should be screened for cutaneous fungal infections before and during treatment, in order to exclude a concomitant infection or the risk of its exacerbation.</div></div>","PeriodicalId":51724,"journal":{"name":"Medical Mycology Case Reports","volume":"46 ","pages":"Article 100683"},"PeriodicalIF":1.6000,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Challenging case of tinea corporis and faciei in psoriatic patient treated with bimekizumab: The usefulness of mycological screening before biological therapies\",\"authors\":\"Terenzio Cosio , Ruslana Gaeta Shumak , Cristiana Borselli , Fabio Artosi , Roberta Gaziano , Elena Campione\",\"doi\":\"10.1016/j.mmcr.2024.100683\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Psoriasis is a multifactorial immune-mediated disorder linked to the interleukin (IL)-17 signalling pathway. We present an unusual case of <em>tinea corporis</em> and <em>faciei</em> caused by <em>Trichophyton tonsurans</em> that developed after starting the IL-17A/F inhibitor bimekizumab. Our case underlines how psoriatic patients, treated with IL-17 inhibitors, should be screened for cutaneous fungal infections before and during treatment, in order to exclude a concomitant infection or the risk of its exacerbation.</div></div>\",\"PeriodicalId\":51724,\"journal\":{\"name\":\"Medical Mycology Case Reports\",\"volume\":\"46 \",\"pages\":\"Article 100683\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2024-11-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medical Mycology Case Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2211753924000575\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Mycology Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211753924000575","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}

引用次数: 0

摘要

银屑病是一种多因素免疫介导的疾病，与白细胞介素（IL）-17 信号通路有关。我们介绍了一个由扁桃体毛癣菌引起的体癣和面癣的罕见病例，该病例是在开始使用 IL-17A/F 抑制剂 bimekizumab 后出现的。我们的病例强调了接受 IL-17 抑制剂治疗的银屑病患者在治疗前和治疗期间应如何筛查皮肤真菌感染，以排除并发感染或感染加重的风险。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Challenging case of tinea corporis and faciei in psoriatic patient treated with bimekizumab: The usefulness of mycological screening before biological therapies

Psoriasis is a multifactorial immune-mediated disorder linked to the interleukin (IL)-17 signalling pathway. We present an unusual case of tinea corporis and faciei caused by Trichophyton tonsurans that developed after starting the IL-17A/F inhibitor bimekizumab. Our case underlines how psoriatic patients, treated with IL-17 inhibitors, should be screened for cutaneous fungal infections before and during treatment, in order to exclude a concomitant infection or the risk of its exacerbation.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Medical Mycology Case Reports MEDICINE, RESEARCH & EXPERIMENTAL-

CiteScore

4.00

自引率

0.00%

发文量

审稿时长

47 days